Is Buying Indivior PLC Here a Winning Strategy?

 Is Buying Indivior PLC Here a Winning Strategy?

The stock of Indivior PLC (LON:INDV) hit a new 52-week high and has GBX 609.66 target or 65.00% above today’s GBX 369.49 share price. The 6 months bullish chart indicates low risk for the GBX 2.65B company. The 1-year high was reported on Nov, 3 by Barchart.com. If the GBX 609.66 price target is reached, the company will be worth GBX 1.72 billion more.
The 52-week high event is an important milestone for every stock because it shows very positive momentum and is time when buyers come in. During such notable technical setup, fundamental investors usually stay away and are careful shorting or selling the stock. The stock increased 5.45% or GBX 19.09 on November 3, hitting GBX 369.49. About 5.00 million shares traded hands or 120.26% up from the average. Indivior PLC (LON:INDV) has risen 121.22% since April 6, 2016 and is uptrending. It has outperformed by 120.01% the S&P500.

Indivior PLC (LON:INDV) Ratings Coverage

Out of 8 analysts covering Indivior Plc (LON:INDV), 6 rate it a “Buy”, 0 “Sell”, while 2 “Hold”. This means 75% are positive. GBX 450 is the highest target while GBX 140 is the lowest. The GBX 340 average target is -7.98% below today’s (GBX 369.49) stock price. Indivior Plc has been the topic of 69 analyst reports since July 29, 2015 according to StockzIntelligence Inc. The firm earned “Buy” rating on Wednesday, November 25 by Stifel Nicolaus. Deutsche Bank maintained Indivior PLC (LON:INDV) on Thursday, August 11 with “Buy” rating. Jefferies maintained Indivior PLC (LON:INDV) on Wednesday, August 17 with “Buy” rating. On Wednesday, November 25 the stock rating was maintained by Jefferies with “Buy”. The company was maintained on Wednesday, August 17 by Cantor Fitzgerald. Citigroup maintained Indivior PLC (LON:INDV) rating on Wednesday, May 4. Citigroup has “Buy” rating and GBX 230 price target. The rating was maintained by Deutsche Bank on Friday, April 29 with “Buy”. The stock of Indivior PLC (LON:INDV) earned “Buy” rating by Deutsche Bank on Tuesday, October 4. The rating was maintained by Jefferies on Thursday, February 18 with “Buy”. The firm has “Neutral” rating given on Tuesday, July 19 by Citigroup.

More important recent Indivior PLC (LON:INDV) news were published by: Prnewswire.com which released: “Indivior PLC Announces Positive Top-line Results From Pivotal Phase 3 Trial of …” on May 05, 2015, also Fool.Co.Uk published article titled: “Will Indivior plc (+71%), Serco Group plc (+33%) & Indus Gas Limited (+105 …”, Fool.Co.Uk published: “Are GlaxoSmithKline plc and Indivior plc the perfect pharma pairing?” on May 31, 2016. More interesting news about Indivior PLC (LON:INDV) was released by: Fool.Co.Uk and their article: “Indivior PLC Scraps Dividend: Should You Sell And Buy AstraZeneca plc Or Shire …” with publication date: February 18, 2016.

Indivior PLC is a specialty pharmaceutical company. The company has a market cap of 2.65 billion GBP. The Firm is engaged in the development, manufacture and sale of prescription drugs that are based on buprenorphine for treatment of opioid dependence segment. It currently has negative earnings. The Company’s treatment and pipeline focuses on opioid use disorder, alcohol use disorder, overdose rescue and co-morbidities of addiction/schizophrenia.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Related posts

Leave a Comment